John F. Ginascol, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 126,400 shares at $95.57 ($12.1M) on 2020-04-21, disclosed to the SEC on 2020-04-23.
Open-market sale of $12.1M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.57 | 23,966 | $2.3M | 18.9% |
| 2 | $95.57 | 23,966 | $2.3M | 18.9% |
| 3 | $96.26 | 39,234 | $3.8M | 31.1% |
| 4 | $96.26 | 39,234 | $3.8M | 31.1% |
| Total | $96.00 avg | 126,400 | $12.1M | 100% |
| Filing → |
| ABT | SELL | 2022-03-02 | $43K | — | Filing → |
| ABT | SELL | 2021-03-02 | $42K | — | Filing → |
| ABT | SELL | 2020-03-03 | $591K | — | Filing → |